An event aimed at finding a cure for Lou Gehrig’s disease, also known as ALS, is set to happen in South Alabama this weekend.
Stem cell therapy is emerging as a promising and effective treatment for neurodegenerative diseases. Popular as Lou Gehrig’s ...
Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...
The Walk to Defeat ALS funds research, treatment, and a cure for Lou Gehrig’s Disease, otherwise known as ALS. The funds will ...
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...
The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...
Furthermore, "given that I'm a frequent participant in international conferences on ALS, I can tell you that there are several treatments or treatment approaches in the pipeline," he said. Ruben J.
Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative diseases, is seeking approval for a new medication for ALS (amyotrophic lateral sclerosis).
Leal Therapeutics has secured yet another multi-million financing deal as the Worcester-based biotechnology startup has ...